聚烯酸提取物:从抗糖活性到体外生物可访问性和体内研究
Giulia Moretto1,2, Raffaella Colombo1, Stefano Negri2,3
1Drug Sciences Department, University of Pavia, 27100 Pavia, Italy.
Nutrients
|January 10, 2026
概括
阿洛西亚花叶提取物通过抑制先进的糖化终产物 (AGE) 形成,显示出强大的抗糖化特性. 需要进一步的配方来提高其稳定性和可用于潜在的食品应用的生物可访问性.
科学领域:
- 植物化学 植物化学
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 先进的糖化终端产品 (AGEs) 由于蛋白质修饰和RAGE激活,与慢性疾病有关.
- 植物二次代谢物可以通过各种机制抵消糖化.
- 艾洛西亚花叶的多烯酸提取物被探索为抗糖性化合物的潜在来源.
研究的目的:
- 为了描述Aloysia citrodora的多基提取物.
- 评估其体外抗糖性质和RAGE相互作用潜力.
- 在模拟消化过程中评估代谢物的稳定性和生物可访问性.
主要方法:
- RP-HPLC-DAD-MSn用于提取物的表征.
- 在体外糖化试验和甲基酸/酸捕获.
- 对RAGE相互作用的分子对接研究.
- 在体外消化模型来评估生物可访问性和活性.
主要成果:
- 提取物含有丰富的虹膜糖化物,类糖化物和黄素,显著抑制了AGE的形成.
- 观察到高甲基甘和甘的捕获能力.
- 消化减少了提取物稳定性和抗糖活性,生物可访问性约40%.
- 分子建模证实了代谢物与RAGE结合.
结论:
- 阿洛西亚是一种有前途的天然抗糖剂的来源,用于食品应用.
- 通过配方来提高提取物的生物可访问性和稳定性至关重要.
- 进一步的研究应侧重于优化输送系统,以保持抗糖药疗效.
关键词:
阿洛西亚花 (Aloysia citrodora) 可食用叶片提取物愤怒的愤怒 愤怒的愤怒与衰老相关的疾病.生物可访问性 生物可访问性分子建模分子建模自然抗糖剂是一种天然的抗糖剂.这是一种Verbascoside.更多相关视频
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
19.8K
07:05Author Spotlight: Eco-Friendly Extraction of Bioactive Compounds Using Polyol-Based Microwave-Assisted Techniques
Published on: August 23, 2024
2.7K
相关概念视频
Methods for Studying Drug Absorption: In vitro
569
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
569
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
521
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
521
